Viewing nowRozastat Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

MFDS item code 200600222 · Notified 2006.02.08 · Insurance code 650200440
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medication is used to manage blood pressure in patients with hypertension. It is particularly helpful in preventing and treating kidney disease in patients who have both hypertension and type 2 diabetes. Therefore, it is effective in controlling blood pressure while improving kidney damage caused by diabetes.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. If pregnancy is confirmed, this medication should be stopped immediately, and tests may be required to check the health of the fetus. This medication should not be administered to patients with severely impaired liver function, certain genetic disorders, or a history of angioedema. Elderly patients or patients with weakened kidney function, or high serum potassium levels should use this medication with caution, requiring regular blood tests and blood pressure monitoring. This medication can lower blood pressure, which may result in symptoms of hypotension or loss of consciousness; if symptoms occur, medical personnel should be notified immediately. Additionally, this medication can elevate potassium levels, so it is important not to take it with potassium supplements or medications containing potassium. Regular tests should be conducted during the use of this medication to ensure there are no abnormalities in liver and kidney function, and if symptoms arise, immediate consultation with a doctor is necessary. This medication is not recommended for breastfeeding women; if it must be taken, breastfeeding should be discontinued. Since it is a blood pressure control medication, caution is required when driving or operating machinery as dizziness may occur. Overdose can lead to hypotension and cardiac arrhythmias, so adherence to the prescribed dosage is essential, and immediate hospital visit is necessary if any abnormal symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, avoid storing it in extremely hot or cold places, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius.
White oval film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.